Goldman Sachs’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Buy
260,543
+36,211
+16% +$2.48M ﹤0.01% 2864
2025
Q4
$15.6M Sell
224,332
-280,064
-56% -$11.4M ﹤0.01% 2626
2025
Q3
$14.1M Buy
504,396
+284,222
+129% +$5.66M ﹤0.01% 2623
2025
Q2
$4.57M Sell
220,174
-104,261
-32% -$2.29M ﹤0.01% 3513
2025
Q1
$5.62M Sell
324,435
-258,430
-44% -$6.33M ﹤0.01% 3233
2024
Q4
$15.8M Sell
582,865
-129,930
-18% -$4.61M ﹤0.01% 2355
2024
Q3
$31.3M Buy
712,795
+30,432
+4% +$1.18M 0.01% 1656
2024
Q2
$26.8M Buy
682,363
+233,692
+52% +$9.6M 0.01% 1639
2024
Q1
$19.2M Buy
448,671
+20,936
+5% +$883K ﹤0.01% 1871
2023
Q4
$17.4M Buy
427,735
+356,302
+499% +$20.4M ﹤0.01% 2028
2023
Q3
$3.6M Buy
+71,433
New +$2.3M ﹤0.01% 3289

Other funds holding GPCR